Influenza virus and chromatin: Role of the CHD1 chromatin remodeler in the virus life cycle

Journal of Virology

Volumn 90, Issue 7, 2016, Pages 3694-3707

  Marcos Villar, Laura ^a,b   Pazo, Alejandra ^a,b   Nieto, Amelia ^a,b  

^a CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMODOMAIN HELICASE DNA BINDING PROTEIN 1; HISTONE H3K4ME3; NUCLEAR PROTEIN; RNA POLYMERASE II; UNCLASSIFIED DRUG; VIRUS ENZYME; CHD1 PROTEIN, HUMAN; CHROMATIN; DNA BINDING PROTEIN; DNA HELICASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHROMATIN; CHROMATIN STRUCTURE; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; ENZYME ACTIVITY; ENZYME DEGRADATION; GENE SILENCING; HISTONE MODIFICATION; HUMAN; HUMAN CELL; INFLUENZA VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RNA TRANSCRIPTION; TRANSCRIPTION REGULATION; VIRAL PHENOMENA AND FUNCTIONS; VIROGENESIS; VIRUS CELL INTERACTION; VIRUS LIFE CYCLE; VIRUS RECOMBINANT; VIRUS TRANSCRIPTION; VIRUS VIRULENCE; CELL LINE; ENZYMOLOGY; EPITHELIUM CELL; HOST PATHOGEN INTERACTION; METABOLISM; ORTHOMYXOVIRIDAE; PHYSIOLOGY; VIROLOGY; VIRUS REPLICATION;

CELL LINE; CHROMATIN; DNA HELICASES; DNA-BINDING PROTEINS; EPITHELIAL CELLS; HOST-PATHOGEN INTERACTIONS; HUMANS; ORTHOMYXOVIRIDAE; VIRUS REPLICATION;

EID: 84960982030     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00053-16     Document Type: Article

References (76)

1. Resa-Infante P, Jorba N, Coloma R, Ortin J. 2011. The influenza virus RNA synthesis machine: advances in its structure and function. RNA Biol 8:207-215. http://dx.doi.org/10.4161/rna.8.2.14513.
2. Martín-Benito J, Ortin J. 2013. Influenza virus transcription and replication. Adv Virus Res 87:113-137. http://dx.doi.org/10.1016/B978-0-12-407698-3.00004-1.
3. Plotch SJ, Bouloy M, Ulmanen I, Krug RM. 1981. A unique cap(m7GpppXm)-dependent influenza virion endonuclease cleaves capped RNAs to generate the primers that initiate viralRNAtranscription. Cell 23:847-858. http://dx.doi.org/10.1016/0092-8674(81)90449-9.
4. Dias A, Bouvier D, Crepin T, McCarthy AA, Hart DJ, Baudin F, Cusack S, Ruigrok RW. 2009. The cap-snatching endonuclease of influenza virus polymerase resides in the PA subunit. Nature 458:914-918. http://dx.doi.org/10.1038/nature07745.
5. Honda A, Okamoto T, Ishihama A. 2007. Host factor Ebp1: selective inhibitor of influenza virus transcriptase. Genes Cells 12:133-142. http://dx.doi.org/10.1111/j.1365-2443.2007.01047.x.
6. Jorba N, Juarez S, Torreira E, Gastaminza P, Zamarreno N, Albar JP, Ortin J. 2008. Analysis of the interaction of influenza virus polymerase complex with human cell factors. Proteomics 8:2077-2088. http://dx.doi.org/10.1002/pmic.200700508.
7. Landeras-Bueno S, Jorba N, Perez-Cidoncha M, Ortin J. 2011. The splicing factor proline-glutamine rich (SFPQ/PSF) is involved in influenza virus transcription. PLoS Pathog 7:e1002397. http://dx.doi.org/10.1371/journal.ppat.1002397.
8. Huarte M, Sanz-Ezquerro JJ, Roncal F, Ortín J, Nieto A. 2001. PA subunit from influenza virus polymerase complex interacts with a cellular protein with homology to a family of transcriptional activators. J Virol 75:8597-8604. http://dx.doi.org/10.1128/JVI.75.18.8597-8604.2001.
9. Rodriguez A, Pére-González A, Nieto A. 2011. Cellular human CLE/c14orf166 protein interacts with influenza virus polymerase and is required for viral replication. J Virol 85:12062-12066. http://dx.doi.org/10.1128/JVI.00684-11.
10. Engelhardt OG, Smith M, Fodor E. 2005. Association of the influenza A virus RNA-dependent RNA polymerase with cellular RNA polymerase II. J Virol 79:5812-5818. http://dx.doi.org/10.1128/JVI.79.9.5812-5818.2005.
11. Bukrinskaya AG, Vorkunova GK, Vorkunova NK. 1979. Cytoplasmic and nuclear input virus RNPs in influenza virus-infected cells. J Gen Virol 45:557-567. http://dx.doi.org/10.1099/0022-1317-45-3-557.
12. Jackson DA, Caton AJ, McCready SJ, Cook PR. 1982. Influenza virus RNA is synthesized at fixed sites in the nucleus. Nature 296:366-368. http://dx.doi.org/10.1038/296366a0.
13. López-Turiso JA, Martinez C, Tanaka T, Ortin J. 1990. The synthesis of influenza virus negative-strand RNA takes place in insoluble complexes present in the nuclear matrix fraction. Virus Res 16:325-337. http://dx.doi.org/10.1016/0168-1702(90)90056-H.
14. Bui M, Wills EG, Helenius A, Whittaker GR. 2000. Role of the influenza virus M1 protein in nuclear export of viral ribonucleoproteins. J Virol 74:1781-1786. http://dx.doi.org/10.1128/JVI.74.4.1781-1786.2000.
15. Chase GP, Rameix-Welti MA, Zvirbliene A, Zvirblis G, Gotz V, WolffT, Naffakh N, Schwemmle M. 2011. Influenza virus ribonucleoprotein complexes gain preferential access to cellular export machinery through chromatin targeting. PLoS Pathog 7:e1002187. http://dx.doi.org/10.1371/journal.ppat.1002187.
16. Takizawa N, Watanabe K, Nouno K, Kobayashi N, Nagata K. 2006. Association of functional influenza viral proteins and RNAs with nuclear chromatin and sub-chromatin structure. Microbes Infect 8:823-833. http://dx.doi.org/10.1016/j.micinf.2005.10.005.
17. Hu Y, Liu X, Zhang A, Zhou H, Liu Z, Chen H, Jin M. 12 September 2014. CHD3 facilitates vRNP nuclear export by interacting with NES1 of influenza A virus NS2. Cell Mol Life Sci http://dx.doi.org/10.1007/s00018-014-1726-9.
18. Alfonso R, Lutz T, Rodriguez A, Chavez JP, Rodriguez P, Gutierrez S, Nieto A. 2011. CHD6 chromatin remodeler is a negative modulator of influenza virus replication that relocates to inactive chromatin upon infection. Cell Microbiol 13:1894-1906. http://dx.doi.org/10.1111/j.1462-5822.2011.01679.x.
19. Flanagan JF, Blus BJ, Kim D, Clines KL, Rastinejad F, Khorasanizadeh S. 2007. Molecular implications of evolutionary differences in CHD double chromodomains. J Mol Biol 369:334-342. http://dx.doi.org/10.1016/j.jmb.2007.03.024.
20. Yap KL, Zhou MM. 2011. Structure and mechanisms of lysine methylation recognition by the chromodomain in gene transcription. Biochemistry 50:1966-1980. http://dx.doi.org/10.1021/bi101885m.
21. Flanagan JF, Mi LZ, Chruszcz M, Cymborowski M, Clines KL, Kim Y, Minor W, Rastinejad F, Khorasanizadeh S. 2005. Double chromodomains cooperate to recognize the methylated histone H3 tail. Nature 438: 1181-1185. http://dx.doi.org/10.1038/nature04290.
22. Sims RJ, III, Chen CF, Santos-Rosa H, Kouzarides T, Patel SS, Reinberg D. 2005. Human but not yeast CHD1 binds directly and selectively to histone H3 methylated at lysine 4 via its tandem chromodomains. J Biol Chem 280:41789-41792. http://dx.doi.org/10.1074/jbc. C500395200.
23. Clapier CR, Cairns BR. 2009. The biology of chromatin remodeling complexes. Annu Rev Biochem 78:273-304. http://dx.doi.org/10.1146/annurev.biochem.77.062706.153223.
24. Rodriguez A, Pérez-Gonzalez A, Nieto A. 2007. Influenza virus infection causes specific degradation of the largest subunit of cellularRNApolymerase II. J Virol 81:5315-5324. http://dx.doi.org/10.1128/JVI.02129-06.
25. Rodriguez A, Perez-Gonzalez A, Hossain MJ, Chen LM, Rolling T, Perez-Brena P, Donis R, Kochs G, Nieto A. 2009. Attenuated strains of influenza A viruses do not induce degradation of RNA polymerase II. J Virol 83:11166-11174. http://dx.doi.org/10.1128/JVI.01439-09.
26. Vreede FT, Chan AY, Sharps J, Fodor E. 2010. Mechanisms and functional implications of the degradation of host RNA polymerase II in influenza virus infected cells. Virology 396:125-134. http://dx.doi.org/10.1016/j.virol.2009.10.003.
27. Llompart CM, Nieto A, Rodriguez-Frandsen A. 2014. Specific residues of PB2 and PA influenza virus polymerase subunits confer the ability for RNA polymerase II degradation and virus pathogenicity in mice. J Virol 88:3455-3463. http://dx.doi.org/10.1128/JVI.02263-13.
28. Alfonso R, Rodriguez A, Rodriguez P, Lutz T, Nieto A. 2013. CHD6, a cellular repressor of influenza virus replication, is degraded in human alveolar epithelial cells and mice [sic] lungs during infection. J Virol 87: 4534-4544. http://dx.doi.org/10.1128/JVI.00554-12.
29. Lin JJ, Lehmann LW, Bonora G, Sridharan R, Vashisht AA, Tran N, Plath K, Wohlschlegel JA, Carey M. 2011. Mediator coordinates PIC assembly with recruitment of CHD1. Genes Dev 25:2198-2209. http://dx.doi.org/10.1101/gad.17554711.
30. Krogan NJ, Kim M, Ahn SH, Zhong G, Kobor MS, Cagney G, Emili A, Shilatifard A, Buratowski S, Greenblatt JF. 2002. RNA polymerase II elongation factors of Saccharomyces cerevisiae: a targeted proteomic approach. Mol Cell Biol 22:6979-6992. http://dx.doi.org/10.1128/MCB.22.20.6979-6992.2002.
31. Warner MH, Roinick KL, Arndt KM. 2007. Rtf1 is a multifunctional component of the Paf1 complex that regulates gene expression by directing cotranscriptional histone modification. Mol Cell Biol 27:6103-6115. http://dx.doi.org/10.1128/MCB.00772-07.
32. Yao H, Pan J, Wu C, Shen H, Xie J, Wang Q, Wen L, Ma L, Wu L, Ping N, Zhao Y, Sun A, Chen S. 2015. Transcriptome sequencing reveals CHD1as a novel fusion partner ofRUNX1in acute myeloid leukemia with t(5;21)(q21;q22). Mol Cancer 14:81. http://dx.doi.org/10.1186/s12943-015-0353-x.
33. Falcón A, Marión R, Zürcher T, Gomez P, Portela A, Nieto A, Ortín J. 2004. Defective RNA replication and late gene expression in temperaturesensitive influenza viruses expressing deleted forms of the NS1 protein. J Virol 78:3880-3888. http://dx.doi.org/10.1128/JVI.78.8.3880-3888.2004.
34. Perales B, Sanz-Ezquerro JJ, Gastaminza P, Ortega J, Fernandez-Santarén J, Ortín J, Nieto A. 2000. The replication activity of influenza virus polymerase is linked to the capacity of the PA subunit to induce proteolysis. J Virol 74:1307-1312. http://dx.doi.org/10.1128/JVI.74.3.1307-1312.2000.
35. Dull T, Zufferey R, Kelly M, Mandel RJ, Nguyen M, Trono D, Naldini L. 1998. A third-generation lentivirus vector with a conditional packaging system. J Virol 72:8463-8471.
36. Stewart SA, Dykxhoorn DM, Palliser D, Mizuno H, Yu EY, An DS, Sabatini DM, Chen IS, Hahn WC, Sharp PA, Weinberg RA, Novina CD. 2003. Lentivirus-delivered stable gene silencing by RNAi in primary cells. RNA 9:493-501. http://dx.doi.org/10.1261/rna.2192803.
37. Levitz SM, Diamond RD. 1985. A rapid colorimetric assay of fungal viability with the tetrazolium salt MTT. J Infect Dis 152:938-945. http://dx.doi.org/10.1093/infdis/152.5.938.
38. Huarte M, Falcón A, Nakaya Y, Ortín J, García-Sastre A, Nieto A. 2003. Threonine 157 of influenza virus PA polymerase subunit modulates RNA replication in infectious viruses. J Virol 77:6007-6013. http://dx.doi.org/10.1128/JVI.77.10.6007-6013.2003.
39. Jones JC, Phatnani HP, Haystead TA, MacDonald JA, Alam SM, Greenleaf AL. 2004. C-terminal repeat domain kinase I phosphorylates Ser2 and Ser5 of RNA polymerase II C-terminal domain repeats. J Biol Chem 279: 24957-24964. http://dx.doi.org/10.1074/jbc. M402218200.
40. Bárcena J, de la Luna S, Ochoa M, Melero JA, Nieto A, Ortín J, Portela A. 1994. Monoclonal antibodies against the influenza virus PB2 and NP polypeptides interfere with the initiation step of viral mRNA synthesis in vitro. J Virol 68:6900-6909.
41. González S, Ortín J. 1999. Distinct regions of influenza virus PB1 polymerase subunit recognize vRNA and cRNA templates. EMBO J 18:3767-3775. http://dx.doi.org/10.1093/emboj/18.13.3767.
42. Jorba N, Coloma R, Ortin J. 2009. Genetic trans-complementation establishes a new model for influenza virus RNA transcription and replication. PLoS Pathog 5:e1000462. http://dx.doi.org/10.1371/journal.ppat.1000462.
43. Lutz T, Stoger R, Nieto A. 2006. CHD6 is a DNA-dependent ATPase and localizes at nuclear sites of mRNA synthesis. FEBS Lett 580:5851-5857. http://dx.doi.org/10.1016/j.febslet.2006.09.049.
44. Robb NC, Smith M, Vreede FT, Fodor E. 2009. NS2/NEP protein regulates transcription and replication of the influenza virus RNA genome. J Gen Virol 90:1398-1407. http://dx.doi.org/10.1099/vir.0.009639-0.
45. Kawakami E, Watanabe T, Fujii K, Goto H, Watanabe S, Noda T, Kawaoka Y. 2011. Strand-specific real-time RT-PCR for distinguishing influenza vRNA, cRNA, and mRNA. J Virol Methods 173:1-6. http://dx.doi.org/10.1016/j.jviromet.2010.12.014.
46. Simic R, Lindstrom DL, Tran HG, Roinick KL, Costa PJ, Johnson AD, Hartzog GA, Arndt KM. 2003. Chromatin remodeling protein Chd1 interacts with transcription elongation factors and localizes to transcribed genes. EMBO J 22:1846-1856. http://dx.doi.org/10.1093/emboj/cdg179.
47. Zentner GE, Tsukiyama T, HenikoffS. 2013. ISWI and CHD chromatin remodelers bind promoters but act in gene bodies. PLoS Genet 9:e1003317. http://dx.doi.org/10.1371/journal.pgen.1003317.
48. Burgui I, Yángüez E, Sonenber N, Nieto A. 2007. Influenza mRNA translation revisited: is the eIF4E cap-binding factor required for viral mRNA translation? J Virol 81:12427-12438. http://dx.doi.org/10.1128/JVI.01105-07.
49. de Lucas S, Peredo J, Marion RM, Sanchez C, Ortin J. 2010. Human Staufen1 protein interacts with influenza virus ribonucleoproteins and is required for efficient virus multiplication. J Virol 84:7603-7612. http://dx.doi.org/10.1128/JVI.00504-10.
50. Jao CY, Salic A. 2008. Exploring RNA transcription and turnover in vivo by using click chemistry. Proc Natl Acad Sci U S A 105:15779-15784. http://dx.doi.org/10.1073/pnas.0808480105.
51. Mena I, de la Luna S, Albo C, Martín J, Nieto A, Ortín J, Portela A. 1994. Synthesis of biologically active influenza virus core proteins using a vaccinia-T7 RNA polymerase expression system. J Gen Virol 75:2109-2114. http://dx.doi.org/10.1099/0022-1317-75-8-2109.
52. Fodor E, Palese P, Brownlee GG, García-Sastre A. 1998. Attenuation of influenza A virus mRNA levels by promoter mutations. J Virol 72:6283-6290.
53. Hay AJ, Lomniczi B, Bellamy AR, Skehel JJ. 1977. Transcription of the influenza virus genome. Virology 83:337-355. http://dx.doi.org/10.1016/0042-6822(77)90179-9.
54. Aparicio O, Razquin N, Zaratiegui M, Narvaiza I, Fortes P. 2006. Adenovirus virus-associated RNA is processed to functional interfering RNAs involved in virus production. J Virol 80:1376-1384. http://dx.doi.org/10.1128/JVI.80.3.1376-1384.2006.
55. Dey P, Ponnusamy MP, Deb S, Batra SK. 2011. Human RNA polymerase II-association factor 1 (hPaf1/PD2) regulates histone methylation and chromatin remodeling in pancreatic cancer. PLoS One 6:e26926. http://dx.doi.org/10.1371/journal.pone.0026926.
56. Allen BL, Taatjes DJ. 2015. The Mediator complex: a central integrator of transcription. Nat Rev Mol Cell Biol 16:155-166. http://dx.doi.org/10.1038/nrm3951.
57. Björklund S, Gustafsson CM. 2005. The yeast Mediator complex and its regulation. Trends Biochem Sci 30:240-244. http://dx.doi.org/10.1016/j.tibs.2005.03.008.
58. Tran HG, Steger DJ, Iyer VR, Johnson AD. 2000. The chromo domain protein Chd1p from budding yeast is an ATP-dependent chromatinmodifying factor. EMBO J 19:2323-2331. http://dx.doi.org/10.1093/emboj/19.10.2323.
59. Torchy MP, Hamiche A, Klaholz BP. 22 March 2015. Structure and function insights into the NuRD chromatin remodeling complex. Cell Mol Life Sci http://dx.doi.org/10.1007/s00018-015-1880-8.
60. Le Guezennec X, Vermeulen M, Brinkman AB, Hoeijmakers WA, Cohen A, Lasonder E, Stunnenberg HG. 2006. MBD2/NuRD and MBD3/NuRD, two distinct complexes with different biochemical and functional properties. Mol Cell Biol 26:843-851. http://dx.doi.org/10.1128/MCB.26.3.843-851.2006.
61. Nioi P, Nguyen T, Sherratt PJ, Pickett CB. 2005. The carboxyterminal Neh3 domain of Nrf2 is required for transcriptional activation. Mol Cell Biol 25:10895-10906. http://dx.doi.org/10.1128/MCB.25.24.10895-10906.2005.
62. Gui Y, Guo G, Huang Y, Hu X, Tang A, Gao S, Wu R, Chen C, Li X, Zhou L, He M, Li Z, Sun X, Jia W, Chen J, Yang S, Zhou F, Zhao X, Wan S, Ye R, Liang C, Liu Z, Huang P, Liu C, Jiang H, Wang Y, Zheng H, Sun L, Liu X, Jiang Z, Feng D, Wu S, Zou J, Zhang Z, Yang R, Zhao J, Xu C, Yin W, Guan Z, Ye J, Zhang H, Li J, Kristiansen K, Nickerson ML, Theodorescu D, Li Y, Zhang X, Li S, Wang J, Yang H, Cai Z. 2011. Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder. Nat Genet 43:875-878. http://dx.doi.org/10.1038/ng.907.
63. Mouradov D, Sloggett C, Jorissen RN, Love CG, Li S, Burgess AW, Arango D, Strausberg RL, Buchanan D, Wormald S, O'Connor L, Wilding JL, Bicknell D, Tomlinson IP, Bodmer WF, Mariadason JM, Sieber OM. 2014. Colorectal cancer cell lines are representative models of the main molecular subtypes of primary cancer. Cancer Res 74:3238-3247. http://dx.doi.org/10.1158/0008-5472.CAN-14-0013.
64. Ali Hassan NZ, Mokhtar NM, Kok Sin T, Mohamed Rose I, Sagap I, Harun R, Jamal R. 2014. Integrated analysis of copy number variation and genome-wide expression profiling in colorectal cancer tissues. PLoS One 9:e92553. http://dx.doi.org/10.1371/journal.pone.0092553.
65. Wong MT, Scholvinck EH, Lambeck AJ, van Ravenswaaij-Arts CM. 18 February 2015. CHARGE syndrome: a review of the immunological aspects. Eur J Hum Genet http://dx.doi.org/10.1038/ejhg.2015.7.
66. Batsukh T, Pieper L, Koszucka AM, von Velsen N, Hoyer-Fender S, Elbracht M, Bergman JE, Hoefsloot LH, Pauli S. 2010. CHD8 interacts with CHD7, a protein which is mutated inCHARGEsyndrome. HumMol Genet 19:2858-2866. http://dx.doi.org/10.1093/hmg/ddq189.
67. Rodríguez-Paredes M, Ceballos-Chavez M, Esteller M, Garcia-Dominguez M, Reyes JC. 2009. The chromatin remodeling factor CHD8 interacts with elongating RNA polymerase II and controls expression of the cyclin E2 gene. Nucleic Acids Res 37:2449-2460. http://dx.doi.org/10.1093/nar/gkp101.
68. Shur I, Socher R, Benayahu D. 2006. In vivo association of CReMM/CHD9 with promoters in osteogenic cells. J Cell Physiol 207:374-378. http://dx.doi.org/10.1002/jcp.20586.
69. Hall JA, Georgel PT. 2007. CHD proteins: a diverse family with strong ties. Biochem Cell Biol 85:463-476. http://dx.doi.org/10.1139/O07-063.
70. Bartholomew B. 2014. Regulating the chromatin landscape: structural and mechanistic perspectives. Annu Rev Biochem 83:671-696. http://dx.doi.org/10.1146/annurev-biochem-051810-093157.
71. Guenther MG, Levine SS, Boyer LA, Jaenisch R, Young RA. 2007. A chromatin landmark and transcription initiation at most promoters in human cells. Cell 130:77-88. http://dx.doi.org/10.1016/j.cell.2007.05.042.
72. Shapiro GI, Gurney TJ, Krug RM. 1987. Influenza virus gene expression: control mechanisms at early and late times of infection and nuclearcytoplasmic transport of virus-specific RNAs. J Virol 61:764-773.
73. Menachery VD, Eisfeld AJ, Schafer A, Josset L, Sims AC, Proll S, Fan S, Li C, Neumann G, Tilton SC, Chang J, Gralinski LE, Long C, Green R, Williams CM, Weiss J, Matzke MM, Webb-Robertson BJ, Schepmoes AA, Shukla AK, Metz TO, Smith RD, Waters KM, Katze MG, Kawaoka Y, Baric RS. 2014. Pathogenic influenza viruses and coronaviruses utilize similar and contrasting approaches to control interferon-stimulated gene responses. mBio 5:e01174-14. http://dx.doi.org/10.1128/mBio.01174-14.
74. Marazzi I, Ho JS, Kim J, Manicassamy B, Dewell S, Albrecht RA, Seibert CW, Schaefer U, Jeffrey KL, Prinjha RK, Lee K, Garcia-Sastre A, Roeder RG, Tarakhovsky A. 2012. Suppression of the antiviral response by an influenza histone mimic. Nature 483:428-433. http://dx.doi.org/10.1038/nature10892.
75. Li X, Foley EA, Molloy KR, Li Y, Chait BT, Kapoor TM. 2012. Quantitative chemical proteomics approach to identify posttranslational modification-mediated protein-protein interactions. J Am Chem Soc 134: 1982-1985. http://dx.doi.org/10.1021/ja210528v.
76. Ver LS, Marcos-Villar L, Landeras-Bueno S, Nieto A, Ortin J. 22 July 2015. The cellular factor NXP2/MORC3 is a positive regulator for influenza virus multiplication. J Virol http://dx.doi.org/10.1128/JVI.01530-15.